美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Corgi Genomics & Precision Medicine ETF

34.15

+0.24570.72%

盤後：33.90-0.2457-0.72%16:10 EDT

成交量：89

成交額：3,051

市值：256.10萬

市盈率：- -

高：34.15

開：33.90

低：34.15

收：33.90

52周最高：36.54

52周最低：23.88

股本：7.50萬

流通股本：7.50萬

量比：0.10

換手率：0.12%

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

Corgi Genomics & Precision Medicine ETF

交易所：

CBOE

成立時間：

2026

員工人數：

- -

公司地址：

200 West Madison Avenue,Suite 3810,Chicago,Illinois,United States

官網：

http://www.medgenics.com

郵編：

60606-3465

電話：

傳真：

- -

簡介：

Medgenics, Inc.於2000年1月27日在特拉華州成立，其全資附屬公司 Medgenics Medical(以色列）Limited在以色列國依法成立。該公司從事於醫療技術和治療，開發專有創新技術平台，為一千多億美元的蛋白質療法市場提供新的療法。其BiopumpTM平台技術將患者的真皮組織轉成可形成蛋白質的“生物泵”，以在患者體內持續生產治療性蛋白質。當植入患者的皮下組織時，可以提供數月的蛋白療法，而不需要一系列頻繁注射。其Biopump平台技術已被驗證可以使用EPODURETM為貧血治療提供促紅細胞生成素（EPO），且貧血患者的血紅蛋白显示出高水平和穩定性，而這些患者大都是在I/II期用藥達6個月及以上的慢性腎臟病（CKD）患者，且試驗結果显示其中一個病人在長達36月內穩定在高血紅蛋白水平。其Biopump是組織微泵（MO），形成於患者的牙籤大小的皮膚組織，可以產生並分泌特定的蛋白質。該公司已經開發出名為DermaVac的專有設備，以方便微泵的去除和Biopumps的植入。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/GNMX/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GNMX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNMX\",,,,,undefined,":{"symbol":"GNMX","market":"US","secType":"STK","nameCN":"Corgi Genomics & Precision Medicine ETF","latestPrice":34.1467,"timestamp":1789156800000,"preClose":33.901,"halted":0,"volume":89,"hourTrading":{"tag":"盘后","latestPrice":33.901,"preClose":34.1467,"latestTime":"16:10 EDT","volume":6,"amount":204.8802,"timestamp":1789157404565,"change":-0.2457,"changeRate":-0.007195,"amplitude":0},"delay":0,"changeRate":0.007247573817881459,"floatShares":75000,"shares":75000,"eps":0,"marketStatus":"休市中","change":0.2457,"latestTime":"09-11 16:00:00 EDT","open":33.901,"high":34.1467,"low":34.1467,"amount":3051,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1302235200000,"exchange":"CBOE","adjPreClose":33.901,"nav":33.89,"aum":2541750,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":33.901,"preClose":34.1467,"latestTime":"16:10 EDT","volume":6,"amount":204.8802,"timestamp":1789157404565,"change":-0.2457,"changeRate":-0.007195,"amplitude":0},"volumeRatio":0.09619540473038417,"impliedVol":0.2416,"impliedVolPercentile":0.4125},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNMX\",,,,,undefined,":{"symbol":"GNMX","floatShares":75000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.09619540473038417,"shares":75000,"dividePrice":0,"high":34.1467,"amplitude":0,"preClose":33.901,"low":34.1467,"week52Low":23.88,"pbRate":"--","week52High":36.5366,"institutionHeld":0,"latestPrice":34.1467,"eps":0,"divideRate":0,"volume":89,"delay":0,"ttmEps":0,"open":33.901,"prevYearClose":25.56,"prevWeekClose":35.2788,"prevMonthClose":35.0802,"prevQuarterClose":31.0879,"fiveDayClose":35.48,"twentyDayClose":32.1748,"sixtyDayClose":26.5628},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNMX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNMX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNMX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1992790800,"yearFounded":2026,"address":"200 West Madison Avenue,Suite 3810,Chicago,Illinois,United States","zipCode":"60606-3465","officePhone":"855 552 6744"},"stockCompanyDetail":{"websiteUrl":"http://www.medgenics.com","stockEarnings":[{"period":"1week","weight":-0.0321},{"period":"1month","weight":0.0533},{"period":"3month","weight":0.2855},{"period":"6month","weight":0.3359},{"period":"ytd","weight":0.3359}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0106},{"period":"3month","weight":0.0304},{"period":"6month","weight":0.154},{"period":"1year","weight":0.1622},{"period":"ytd","weight":0.1208}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Medgenics, Inc.於2000年1月27日在特拉華州成立，其全資附屬公司 Medgenics Medical(以色列）Limited在以色列國依法成立。該公司從事於醫療技術和治療，開發專有創新技術平台，為一千多億美元的蛋白質療法市場提供新的療法。其BiopumpTM平台技術將患者的真皮組織轉成可形成蛋白質的“生物泵”，以在患者體內持續生產治療性蛋白質。當植入患者的皮下組織時，可以提供數月的蛋白療法，而不需要一系列頻繁注射。其Biopump平台技術已被驗證可以使用EPODURETM為貧血治療提供促紅細胞生成素（EPO），且貧血患者的血紅蛋白显示出高水平和穩定性，而這些患者大都是在I/II期用藥達6個月及以上的慢性腎臟病（CKD）患者，且試驗結果显示其中一個病人在長達36月內穩定在高血紅蛋白水平。其Biopump是組織微泵（MO），形成於患者的牙籤大小的皮膚組織，可以產生並分泌特定的蛋白質。該公司已經開發出名為DermaVac的專有設備，以方便微泵的去除和Biopumps的植入。","exchange":"CBOE","name":"Corgi Genomics & Precision Medicine ETF","nameEN":"Corgi Genomics & Precision Medicine ETF"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"GNMX\",market:\"US\",,,undefined,":null}}